NIP30 inhibitors are chemical compounds that target and modulate the function of the NIP30 protein, also known as nuclear-interacting partner of Ankrd30a. NIP30 is a regulatory protein involved in a range of cellular processes, including cell cycle regulation, gene transcription, and protein-protein interactions. By binding to or interfering with NIP30's active sites, these inhibitors are able to modulate its biological activity, leading to downstream effects on cellular pathways that depend on NIP30-mediated functions. Structurally, NIP30 inhibitors can vary widely but often contain key functional groups designed to fit into the protein's binding pockets, thus inhibiting its ability to interact with other regulatory proteins or DNA elements. Some inhibitors are derived from small-molecule libraries designed for high-affinity interactions, while others are rationally designed based on the crystal structure of NIP30 or related proteins.
The study of NIP30 inhibitors is of interest because of the protein's involvement in transcriptional regulation and cell cycle control, which are key processes for cellular proliferation and survival. These inhibitors can be used as chemical probes to explore the biological function of NIP30 in different contexts, such as understanding its role in chromatin remodeling or in modulating gene expression networks. Through this kind of mechanistic study, researchers can gain insights into how NIP30 contributes to normal cellular homeostasis and how its dysregulation might affect cellular phenotypes. Inhibitors that target proteins like NIP30 are important tools for dissecting complex molecular pathways and identifying the regulatory mechanisms that govern critical cellular processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
This histone deacetylase inhibitor might lead to increased acetylation of histones, promoting a less condensed chromatin state that could downregulate NIP30 gene transcription. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By inhibiting DNA methyltransferases, 5-Azacytidine could decrease methylation levels at the NIP30 promoter, resulting in a decrease in NIP30 expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin binds to the mTOR complex and may suppress protein synthesis, leading to a decrease in the levels of multiple proteins, potentially including NIP30. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D intercalates into DNA and may inhibit RNA polymerase movement, which can lead to reduced transcription of NIP30 mRNA. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide obstructs the translocation step in protein synthesis, potentially leading to a rapid decrease in NIP30 protein levels due to the lack of new synthesis. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $69.00 $266.00 | 8 | |
This inhibitor of inosine monophosphate dehydrogenase may lead to depleted guanine nucleotides, thus reducing cellular proliferation and indirectly inhibiting NIP30 expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid, through its interaction with retinoic acid receptors, may alter the transcriptional control of genes, including a possible downregulation of NIP30. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
As an inhibitor of JNK, SP600125 could suppress the JNK signaling pathway, which might lead to the downregulation of target genes such as NIP30. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002 competitively inhibits PI3K, which could disrupt the PI3K/AKT signaling pathway and lead to the downregulation of proteins, potentially including NIP30. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 selectively inhibits MEK1/2, which might lead to the inhibition of the MAPK/ERK pathway and subsequent decrease in NIP30 protein expression levels. | ||||||